TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma, Journal of Clinical Endocrinology and Metabolism, vol.97, pp.805-809, 2012. ,
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD, Journal of Medical Genetics, vol.55, pp.384-394, 2018. ,
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma, American Journal of Human Genetics, vol.69, pp.49-54, 2001. ,
Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome, Journal of Clinical Endocrinology and Metabolism, vol.100, pp.4498-4504, 2015. ,
Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma, New England Journal of Medicine, vol.354, pp.2729-2731, 2006. ,
, , 2007.
, Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1, Journal of Clinical Endocrinology and Metabolism, vol.92, pp.2784-2792
, , 2014.
, Endocrine-Related Cancer, vol.21, pp.17-25
Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention, JAMA Oncology, vol.3, pp.1204-1212, 2017. ,
Max schottelius: pioneer in pheochromocytoma, Journal of the Endocrine Society, vol.1, pp.957-964, 2017. ,
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients, BMC Medical Genetics, vol.10, p.34, 2009. ,
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma, Lancet Oncology, vol.11, issue.10, pp.70007-70010, 2010. ,
DOI : 10.1016/s1470-2045(10)70007-3
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma, Science, vol.287, pp.848-851, 2000. ,
VHL c.505 T>C mutation confers a high age related penetrance but no increased overall mortality, Journal of Medical Genetics, vol.38, pp.508-514, 2001. ,
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes, Journal of Clinical Endocrinology and Metabolism, vol.91, pp.827-836, 2006. ,
Links TP & Kerstens MN 2018 Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review, European Journal of Internal Medicine, vol.51, pp.68-73 ,
birth incidence, and penetrance of von Hippel-Lindau disease (vHL) in Denmark, European Journal of Human Genetics, vol.25, pp.301-307 ,
Survival and causes of death in patients with von Hippel-Lindau disease, Journal of Medical Genetics, vol.54, pp.11-18, 2017. ,
A SDHC founder mutation causes paragangliomas (PGLs) in the French Canadians: new insights on the SDHC-related PGL, Journal of Clinical Endocrinology and Metabolism, vol.101, pp.4710-4718, 2016. ,
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas, Journal of Clinical Endocrinology and Metabolism, vol.94, pp.2817-2827, 2009. ,
SDHA is a tumor suppressor gene causing paraganglioma, Human Molecular Genetics, vol.19, pp.3011-3020, 2010. ,
2012 MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma, Clinical Cancer Research, vol.18, pp.2828-2837 ,
Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma, Journal of Medical Genetics, vol.54, pp.125-133, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02046528
CC 2016 I-131 metaiodobenzylguanidine therapy of pheochromocytoma and paraganglioma, Seminars in Nuclear Medicine, vol.46, pp.203-214 ,
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene, Journal of the National Cancer Institute, vol.107, p.53, 2015. ,
Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.1392-1396, 2014. ,
SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity, Molecular Genetics and Genomic Medicine, vol.5, pp.237-250, 2017. ,
Clinical and molecular features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): case series and literature review, Journal of Clinical Endocrinology and Metabolism, vol.102, pp.4013-4022, 2017. ,
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study, Lancet Oncology, vol.15, issue.14, pp.70154-70162, 2014. ,
MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma, European Journal of Endocrinology, vol.174, pp.9-18, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01473972
The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations, Endocrine-Related Cancer, vol.24, pp.63-67, 2017. ,
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas, Human Molecular Genetics, vol.23, pp.2440-2446, 2014. ,
, , 2014.
, Germline FH mutations presenting with pheochromocytoma, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.2046-2050
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma, Nature Genetics, vol.43, pp.663-667, 2011. ,
Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma, Endocrine Connections, vol.2, pp.104-111, 2013. ,
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients, Journal of Medical Genetics, vol.52, pp.647-656, 2015. ,
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas, PLoS Genetics, vol.1, pp.72-80, 2005. ,
Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours, European Journal of Endocrinology, vol.176, pp.635-644, 2017. ,
Kerstens MN & van der Horst-Schrivers AN 2017 Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers, Familial Cancer, vol.16, pp.123-130 ,
The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3), Journal of Clinical Endocrinology and Metabolism, vol.99, pp.1482-1486, 2014. ,
Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. Endocrinology, Diabetes and Metabolism Case Reports 2014 140051. phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis, JAMA, vol.276, pp.1575-1579, 2014. ,
Persu A & Dinjens WN 2015 Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations, Genetics in Medicine, vol.17, pp.610-620 ,
, Microsurgery of the Skull Base, pp.149-153, 1988.
Comprehensive molecular characterization of pheochromocytoma and paraganglioma, Cancer Cell, vol.31, pp.181-193, 2017. ,
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.35, pp.1039-1047, 2008. ,
Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1, European Journal of Endocrinology, vol.178, pp.1-9, 2018. ,
Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma, Pathology, vol.45, pp.689-691, 2013. ,
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients, American Journal of Surgical Pathology, vol.38, pp.1588-1602, 2014. ,
Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation, Journal of Clinical Endocrinology and Metabolism, vol.82, pp.3902-3904, 1997. ,
Mutations of the VHL tumour suppressor gene in renal carcinoma, Nature Genetics, vol.7, pp.85-90, 1994. ,
Perioperative alpha-receptor blockade in phaeochromocytoma surgery: an observational case series, British Journal of Anaesthesia, vol.118, pp.182-189, 2017. ,
Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1, Clinical Endocrinology, vol.86, pp.141-149, 2017. ,
Rubenstein A & Viskochil D 1997 The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2, JAMA, vol.278, pp.51-57 ,
, , 2009.
, SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma, Science, vol.325, pp.1139-1142
Recent advances in the genetics of SDHrelated paraganglioma and pheochromocytoma, Familial Cancer, vol.10, pp.355-363, 2011. ,
High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands, Clinical Genetics, vol.81, pp.284-288, 2012. ,
Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association, Virchows Archiv, vol.466, pp.727-732, 2015. ,
PET/CT comparing (68) Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma, European Journal of Nuclear Medicine and Molecular Imaging, vol.43, pp.1784-1791, 2016. ,
SDHBrelated pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations, Journal of Cancer Research and Clinical Oncology, vol.143, pp.1421-1435, 2017. ,
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma, Endocrine-Related Cancer, vol.21, pp.405-414, 2014. ,
Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma, Endocrine-Related Cancer, vol.21, pp.13-16, 2014. ,
Efficacy of peptide receptor radionuclide therapy for functional metastatic paraganglioma and pheochromocytoma, Journal of Clinical Endocrinology and Metabolism, vol.102, pp.3278-3287, 2017. ,
Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis, Journal of Clinical Endocrinology and Metabolism, vol.101, pp.453-460, 2016. ,
, Walenkamp AM & Links TP 2014 Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations, vol.21, pp.63-71
, , 2011.
, SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma, Clinical Cancer Research, vol.17, pp.247-254
Preventive medicine in genetic pheochromocytoma, vol.25 ,
, Endocrine-Related Cancer
Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, vol.260, pp.1317-1320, 1993. ,
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.1915-1942, 2014. ,
SDH mutations establish a hypermethylator phenotype in paraganglioma, Cancer Cell, vol.23, pp.739-752, 2013. ,
Classifiaction of Tumours of Endocrine Organs, 2017. ,
, EH 2003 von Hippel-Lindau disease, vol.361, pp.2059-2067
Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3, Endocrine-Related Cancer, vol.19, pp.283-290, 2012. ,
Gastrointestinal stromal tumors, Gastroenterology Clinics of North America, vol.42, pp.399-415, 2013. ,
Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades, Clinical Endocrinology, vol.87, pp.320-326, 2017. ,
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A, Nature, vol.363, pp.458-460, 1993. ,
Harrison's Principles of Internal Medicine, 2018. ,
Maternal transmission of symptomatic disease with SDHD mutation: fact or fiction, Journal of Clinical Endocrinology and Metabolism, vol.93, pp.1573-1575, 2008. ,
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease, New England Journal of Medicine, vol.329, pp.1531-1538, 1993. ,
, , 2002.
, Germ-line mutations in nonsyndromic pheochromocytoma, New England Journal of Medicine, vol.346, pp.1459-1466
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations, JAMA, vol.292, pp.943-951, 2004. ,
Mutations in SDHC cause autosomal dominant paraganglioma, type 3, Nature Genetics, vol.26, pp.268-270, 2000. ,
Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC, Human Genetics, vol.113, pp.92-94, 2003. ,
The phenotype of SDHB germline mutation carriers: a nationwide study, European Journal of Endocrinology, vol.177, pp.115-125, 2017. ,
SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors, Modern Pathology, vol.26, pp.456-463, 2013. ,
Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma, Human Pathology, vol.46, pp.1951-1955, 2015. ,
, , 2015.
, SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T), vol.28, pp.807-821
, , 2008.
, Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD, European Journal of Human Genetics, vol.16, pp.79-88
Novel SDHB and TMEM127 mutations in patients with pheochromocytoma/paraganglioma syndrome, Pathology and Oncology Research, vol.22, pp.673-679, 2016. ,
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma, Annals of Clinical Biochemistry, vol.50, pp.147-155, 2013. ,
Das Ganglioma embryonale sympathicum (Sympathoma embryonale), eine typische bösartige Geschwulstform des sympathischen Nervensystems, Berliner Klinische Wochenschrift, vol.49, pp.16-22, 1912. ,
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma, Nature Genetics, vol.42, pp.229-233, 2010. ,
Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma, European Journal of Endocrinology, vol.177, pp.103-113, 2017. ,
A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma, Journal of Clinical Endocrinology and Metabolism, vol.98, pp.1248-1256, 2013. ,
Pearson PL & Weatherall DJ 1985 A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16, Nature, vol.317, pp.542-544 ,
DOI : 10.1038/317542a0
, , 2010.
Preventive medicine in genetic pheochromocytoma, vol.25 ,
, Endocrine-Related Cancer risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD, Human Mutations, vol.31, pp.41-51
, , 2012.
, Succinate dehydrogenase kidney cancer: an aggressive example of the warburg effect in cancer, Journal of Urology, vol.188, pp.2063-2071
The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers, Clinical Genetics, vol.93, pp.60-66, 2018. ,
Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review, Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol.57, pp.122-133, 2013. ,
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene, JAMA, vol.294, pp.2057-2063, 2005. ,
The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor, Genes and Development, vol.22, pp.884-893, 2008. ,
Clinicopathologic analysis of ninety cases, American Journal of Surgery, vol.122, pp.732-739, 1971. ,
Role of RET genetic variants in MEN2-associated pheochromocytoma, European Journal of Endocrinology, vol.170, pp.821-828, 2014. ,
Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy, Head and Neck, vol.35, pp.1195-1204, 2013. ,
Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy, European Archives of Oto-Rhino-Laryngology, vol.271, pp.23-34, 2014. ,
Modern trends in the management of head and neck paragangliomas, European Archives of Oto-Rhino-Laryngology, vol.272, pp.3595-3599, 2015. ,
, EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma, vol.39, pp.1977-1995, 2012.
Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene, Genes, Chromosomes and Cancer, vol.31, pp.274-281, 2001. ,
Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases, 2002. ,
, American Journal of Surgical Pathology, vol.26, pp.551-566
The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2, Journal of Clinical Endocrinology and Metabolism, vol.98, pp.1813-1819, 2013. ,
Pheochromocytoma and extra-adrenal paraganglioma: updates, Archives of Pathology and Laboratory Medicine, vol.132, pp.1272-1284, 2008. ,
, Tischler AS & deKrijger RR 2015 15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma, vol.22, pp.123-133
, , 2015.
, Penetrance and clinical features of pheochromocytoma in a sixgeneration family carrying a germline TMEM127 mutation, Journal of Clinical Endocrinology and Metabolism, vol.100, pp.308-318
Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas, Nature Review Endocrinology, vol.13, pp.233-247, 2017. ,
) van Baars F, Cremers C, van den Broek P, Geerts S & Veldman J 1982 Genetic aspects of nonchromaffin paraganglioma, Histopathology, vol.72, pp.305-309, 2018. ,
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, Lancet Oncology, vol.10, issue.09, pp.70164-70164, 2009. ,
,
, Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma, American Journal of Human Genetics, vol.74, pp.153-159
Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients, World Journal of Surgery, vol.30, pp.899-908, 2006. ,
Minimally Invasive Surgery (MIS) in children and adolescents with pheochromocytomas and retroperitoneal paragangliomas: experiences in 42 patients, World Journal of Surgery, vol.42, pp.1024-1030, 2018. ,
Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma, Journal of Clinical Endocrinology and Metabolism, vol.99, pp.1352-1360, 2014. ,
Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects? EndocrineRelated Cancer 19 C33-C40, 2012. ,
, , p.219
Preventive medicine in genetic pheochromocytoma, vol.25 ,
Pituitary adenoma with paraganglioma/ pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice, Journal of Clinical Endocrinology and Metabolism, vol.100, pp.710-719, 2015. ,
, Safran H & Resnick MB 2015 A novel SDHA-deficient renal cell carcinoma revealed by comprehensive genomic profiling
, American Journal of Surgical Pathology, vol.39, pp.858-863
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia, Journal of Molecular Medicine, vol.93, pp.93-104, 2015. ,
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas, JAMA, vol.304, pp.2611-2619, 2010. ,
A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors, Human Genetics, vol.124, pp.279-285, 2008. ,
, , 1996.
, Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, vol.8, pp.348-357, 1996.
Clinical characteristics and strategy for treatment of functional carotid body tumours, International Journal of Oral and Maxillofacial Surgery, vol.42, pp.436-439, 2013. ,